These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1193 related articles for article (PubMed ID: 4712593)

  • 41. Antigenic changes of DBA/2J mastocytoma cells when grown in the BALB/c mouse.
    Wolf JE; Faanes RB; Choi YS
    J Natl Cancer Inst; 1977 May; 58(5):1407-12. PubMed ID: 67213
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immune cytolysis in vitro--a correlate of cellular immunity.
    Macpherson BR; Pilch YH
    J Surg Res; 1972 Mar; 12(3):193-8. PubMed ID: 5020464
    [No Abstract]   [Full Text] [Related]  

  • 43. Cell-mediated cytotoxic reactions to tumor associated antigens.
    Herberman RB
    J Reticuloendothel Soc; 1975 Apr; 17(4):236-40. PubMed ID: 50447
    [No Abstract]   [Full Text] [Related]  

  • 44. Immune cytolysis of murine tumor cells mediated by xenogeneic "immune" RNA.
    Kern DH; Pilch YH
    Int J Cancer; 1974 May; 13(5):679-88. PubMed ID: 4843880
    [No Abstract]   [Full Text] [Related]  

  • 45. [Immunologic aspects of murine allogeneic tumor growth (author's transl)].
    Braun M; Saal F; Pasqualini CD
    Sangre (Barc); 1974; 19(2):153-7. PubMed ID: 4409784
    [No Abstract]   [Full Text] [Related]  

  • 46. Combined cytolytic effect of x irradiation and cell-mediated immune reactions on tumor cells in vitro.
    Song CW; Levitt SH
    Radiology; 1974 Apr; 111(1):211-2. PubMed ID: 4205812
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of cell-wall skeleton of Mycobacterium bovis BCG on cell-mediated cytotoxicity in tumor-bearing mice.
    Taniyama T; Azuma I; Aladin AA; Yamamura Y
    Gan; 1975 Dec; 66(6):705-9. PubMed ID: 817955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Variations of cellular type specific immunological defense mechanisms as a function of tumor growth].
    Barski G; Youn JK; Belehradek J; Le François D
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):633-43. PubMed ID: 5050873
    [No Abstract]   [Full Text] [Related]  

  • 49. [Cellular immunity in mouse plasmocytomas].
    Lespinats G; Poupon MF
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):755-65. PubMed ID: 5050876
    [No Abstract]   [Full Text] [Related]  

  • 50. Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization.
    MacDonald HR; Phillips RA; Miller RG
    J Immunol; 1973 Aug; 111(2):565-74. PubMed ID: 4123983
    [No Abstract]   [Full Text] [Related]  

  • 51. Early onset of serum blocking in a murine melanoma model.
    Bray AE; Holt PG; Roberts LM; Keast D
    Int J Cancer; 1975 Oct; 16(4):607-15. PubMed ID: 1176208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brief communication: In vivo protection against murine plasma cell tumor growth by in vitro activated syngeneic lymphocytes.
    Röllinghoff M; Wagner H
    J Natl Cancer Inst; 1973 Oct; 51(4):1317-8. PubMed ID: 4745860
    [No Abstract]   [Full Text] [Related]  

  • 53. Host immune response to virus-induced tumors. Some recent concepts.
    Aoki T; Chieco-Bianchi L; Plata EJ; Sendo F; Hollis VW; Kudo T
    Prog Exp Tumor Res; 1974; 19():23-36. PubMed ID: 4373781
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects on tumor growth in vivo by manipulation of the tumor immune response.
    Sjögren HO
    Johns Hopkins Med J Suppl; 1974; 3():51-60. PubMed ID: 4370816
    [No Abstract]   [Full Text] [Related]  

  • 55. Enhancing T lymphocytes from tumor-bearing mice suppress host resistance to a syngeneic tumor.
    Treves AJ; Carnaud C; Trainin N; Feldman M; Cohen IR
    Eur J Immunol; 1974 Nov; 4(11):722-7. PubMed ID: 4547711
    [No Abstract]   [Full Text] [Related]  

  • 56. Modulation of the immune response to transplantation antigens. III. Further studies on the effects of Freund's complete adjuvant on the immune response of mice to allogeneic tumour antigen.
    Zola H
    Clin Exp Immunol; 1974 Mar; 16(3):469-79. PubMed ID: 4157121
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Immunologic response to transplantable specific antigens in experimental tumors].
    Porwit-Bóbr Z
    Postepy Hig Med Dosw; 1971; 25(1):25-36. PubMed ID: 4932042
    [No Abstract]   [Full Text] [Related]  

  • 58. Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. I. Development of cellular immunity to simian virus 40 tumor-specific transplantation antigens during tumorigenesis by transplanted cells.
    Zarling JM; Tevethia SS
    J Natl Cancer Inst; 1973 Jan; 50(1):137-47. PubMed ID: 4348218
    [No Abstract]   [Full Text] [Related]  

  • 59. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
    Vilien M
    Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
    [No Abstract]   [Full Text] [Related]  

  • 60. Development of cell-mediated antiviral immunity and macrophage activation in C3H/HeN mice infected with mouse mammary tumor virus.
    Tagliabue A; Boraschi D; McCoy JL
    J Immunol; 1980 May; 124(5):2203-8. PubMed ID: 6245137
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.